LU87229A1 - Nouveaux(omega-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant - Google Patents

Nouveaux(omega-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant Download PDF

Info

Publication number
LU87229A1
LU87229A1 LU87229A LU87229A LU87229A1 LU 87229 A1 LU87229 A1 LU 87229A1 LU 87229 A LU87229 A LU 87229A LU 87229 A LU87229 A LU 87229A LU 87229 A1 LU87229 A1 LU 87229A1
Authority
LU
Luxembourg
Prior art keywords
compound
formula
tetrahydrofurans
tetrahydrothiophenes
preparation
Prior art date
Application number
LU87229A
Other languages
English (en)
French (fr)
Inventor
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of LU87229A1 publication Critical patent/LU87229A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU87229A 1987-05-29 1988-05-27 Nouveaux(omega-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant LU87229A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8712693 1987-05-29
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (1)

Publication Number Publication Date
LU87229A1 true LU87229A1 (fr) 1988-12-13

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87229A LU87229A1 (fr) 1987-05-29 1988-05-27 Nouveaux(omega-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant

Country Status (32)

Country Link
US (1) US5017588A (sv)
JP (1) JPH0631228B2 (sv)
KR (1) KR960005152B1 (sv)
AR (1) AR243885A1 (sv)
AT (1) AT395715B (sv)
AU (1) AU610789B2 (sv)
BE (1) BE1002146A3 (sv)
CA (1) CA1317959C (sv)
CH (1) CH674985A5 (sv)
DE (1) DE3818106A1 (sv)
DK (1) DK167532B1 (sv)
ES (1) ES2009924A6 (sv)
FI (1) FI89353C (sv)
FR (2) FR2615735B1 (sv)
GB (2) GB8712693D0 (sv)
GR (1) GR1000147B (sv)
HK (1) HK101790A (sv)
IE (1) IE61341B1 (sv)
IN (1) IN168799B (sv)
IT (1) IT1219698B (sv)
LU (1) LU87229A1 (sv)
MA (1) MA21289A1 (sv)
MY (1) MY103289A (sv)
NL (1) NL192203C (sv)
NO (1) NO170086C (sv)
NZ (1) NZ224775A (sv)
OA (1) OA08878A (sv)
PT (1) PT87585B (sv)
SE (1) SE466449B (sv)
SG (1) SG93790G (sv)
TN (1) TNSN88049A1 (sv)
ZA (1) ZA883731B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
IE881599L (en) 1988-11-29
KR880013928A (ko) 1988-12-22
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
SG93790G (en) 1991-01-18
ES2009924A6 (es) 1989-10-16
DE3818106A1 (de) 1988-12-15
SE8801964D0 (sv) 1988-05-26
FI882475A (fi) 1988-11-30
FI89353B (fi) 1993-06-15
US5017588A (en) 1991-05-21
AR243885A1 (es) 1993-09-30
NO170086C (no) 1992-09-09
PT87585B (pt) 1992-09-30
FI89353C (sv) 1993-09-27
GB8712693D0 (en) 1987-07-01
HK101790A (en) 1990-12-14
GB2205100A (en) 1988-11-30
FR2615854A1 (fr) 1988-12-02
CA1317959C (en) 1993-05-18
GB2205100B (en) 1990-08-15
ATA140788A (de) 1992-07-15
SE466449B (sv) 1992-02-17
DK291088D0 (da) 1988-05-27
BE1002146A3 (fr) 1990-07-31
PT87585A (pt) 1989-05-31
GR1000147B (el) 1991-09-27
JPH0631228B2 (ja) 1994-04-27
NZ224775A (en) 1990-01-29
GB8812488D0 (en) 1988-06-29
OA08878A (fr) 1989-10-31
FR2615735B1 (fr) 1991-01-11
DK167532B1 (da) 1993-11-15
MA21289A1 (fr) 1988-12-31
NL8801315A (nl) 1988-12-16
IN168799B (sv) 1991-06-08
TNSN88049A1 (fr) 1990-07-10
NO170086B (no) 1992-06-01
FI882475A0 (fi) 1988-05-26
MY103289A (en) 1993-05-29
GR880100342A (en) 1989-02-23
CH674985A5 (sv) 1990-08-15
NL192203B (nl) 1996-11-01
AU610789B2 (en) 1991-05-23
DK291088A (da) 1988-11-30
DE3818106C2 (sv) 1993-07-01
NO882335L (no) 1988-11-30
AT395715B (de) 1993-02-25
NL192203C (nl) 1997-03-04
ZA883731B (en) 1989-02-22
AU1672288A (en) 1988-12-01
IT1219698B (it) 1990-05-24
SE8801964L (sv) 1988-11-30
FR2615735A1 (fr) 1988-12-02
IE61341B1 (en) 1994-11-02
IT8820773A0 (it) 1988-05-27
FR2615854B1 (fr) 1990-12-28
KR960005152B1 (ko) 1996-04-22

Similar Documents

Publication Publication Date Title
EP0099789B1 (fr) Nouveaux dérivés de l'amino-3 quinuclidine, leur procédé de préperation et leur application en thérapeutique
EP1708994B1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EP1095020B1 (fr) Derives de 2-aminopyridines, leur utilisation en tant que medicaments et compositions pharmaceutiques les contenant
EP0684241B1 (fr) N-pyridyl carboxamides et dérivés, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0233793B1 (fr) Dérivés de la décahydroquinoléine, leur procédé de préparation, les intermédiaires de préparation, leur application à titre de médicaments et les compositions les renfermant
EP0382634B1 (fr) Nouveaux dérivés de la pyridazine, procédé de préparation et compositions pharmaceutiques en contenant
EP0022118A1 (fr) Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique
EP0037778A1 (fr) Benzodioxanne 1,4 méthoxy-2 propanolamines, leur préparation et leur application en tant que médicaments
LU87229A1 (fr) Nouveaux(omega-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant
LU83293A1 (fr) Amines antihypertensives,leur procede de preparation et compositions antihypertensives en contenant
CA1131230A (fr) Procede de preparation de nouveaux derives de 1,3-dihydro3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl) 2-hydroxy-ethyl/piperidin-4-yl/2h-indol-2-one
EP0077720B1 (fr) Dérivés de biphényl alcoyl carboxylates, leur procédé de préparation et leur utilisation comme médicaments
LU87114A1 (fr) Nouveaux derives oxy-5 du tetrahydrofurane,un procede pour leur preparation et compositions therapeutiques en contenant
EP0459887A1 (fr) Dérivés N-pyrazolyl-ortho-dialkyl-benzamide doués d'activité anticonvulsivante, procédé de préparation et composition pharmaceutique
EP0395528B1 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
LU87230A1 (fr) Nouveaux methoxy-5 alcoyl ammonium tetrahydrofuranes et tetrahydrothiophenes,un procede pour leur preparation et compositions therapeutiques en contenant
FR2672286A1 (fr) Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
EP0002635B1 (fr) Procédé de préparation de dérivés de thiéno (2,3-c) et (3,2-c) pyridines, nouveaux dérivés de la thiéno (2,3-c) pyridine obtenus et leur application thérapeutique
EP0101380A2 (fr) Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0347305B1 (fr) [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif
FR2587333A1 (fr) Nouveaux ethers allyliques bicycliques, leur preparation et leur utilisation comme anti-fongiques et fongicides
EP0012072A2 (fr) Bêta-lactones dérivées de l'acide 2-hydroxy cyclopentane carboxylique, procédé pour leur préparation et compositions pharmaceutiques les renfermant
EP0187096A1 (fr) Arylalcoyloxymethyl-2 morpholines, leur préparation et leur application en tant que médicaments utiles dans le traitement des troubles du système nerveux central
EP0412898A1 (fr) Nouveaux dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent